Literature DB >> 12633192

Colorectal cancer screening: clinical applications.

Judith M E Walsh1, Jonathan P Terdiman.   

Abstract

Screening for colorectal cancer reduces mortality in individuals aged 50 years or older. A number of screening tests, including fecal occult blood tests, sigmoidoscopy, double-contrast barium enema, and colonoscopy, are recommended by professional organizations for colorectal cancer screening, yet the rates of colorectal cancer screening remain low. Questions regarding the quality of evidence for each screening test, whether screening for individuals at higher risk should be modified, the availability of the tests, and cost-effectiveness are addressed. Many potential barriers to colorectal cancer screening exist for the patient and the physician. Strategies to increase compliance for colorectal cancer screening are proposed.

Entities:  

Mesh：

Year:  2003        PMID： 12633192     DOI： 10.1001/jama.289.10.1297

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


  38 in total

1.  The safety of same-day CT colonography following incomplete colonoscopy with polypectomy.

Authors:  Luis F Lara; Danny Avalos; Huan Huynh; Brenda Jimenez-Cantisano; Mariann Padron; Ronnie Pimentel; Tolga Erim; Alison Schneider; Andrew Ukleja; Albert Parlade; Fernando Castro
Journal:  United European Gastroenterol J       Date:  2015-08       Impact factor: 4.623

Review 2.  Colonoscopy vs CT colonography to screen for colorectal neoplasia in average-risk patients.

Authors:  J M Hardacre; J L Ponsky; M E Baker
Journal:  Surg Endosc       Date:  2005-03       Impact factor: 4.584

3.  Demographic, medical, and psychosocial correlates to CAM use among survivors of colorectal cancer.

Authors:  Catalina Lawsin; Katherine DuHamel; Steven H Itzkowitz; Karen Brown; Helen Lim; Linda Thelemaque; Lina Jandorf
Journal:  Support Care Cancer       Date:  2007-01-05       Impact factor: 3.603

4.  MicroRNAs as potential liquid biopsy biomarkers in colorectal cancer: A systematic review.

Authors:  Yuji Toiyama; Yoshinaga Okugawa; James Fleshman; C Richard Boland; Ajay Goel
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2018-05-29       Impact factor: 10.680

5.  Attitude of the Italian general population towards prevention and screening of the most common tumors, with special emphasis on colorectal malignancies.

Authors:  Federica Domati; Estratios Travlos; Claudia Cirilli; Giuseppina Rossi; Piero Benatti; Massimiliano Marino; Giovanni Ponti; Maria Vandelli; Simone Valmori; Amal Oursana; Annalisa Pezzi; Maurizio Ponz de Leon
Journal:  Intern Emerg Med       Date:  2008-09-20       Impact factor: 3.397

6.  Incidence and survival of patients with Dukes' A (stages T1 and T2) colorectal carcinoma: a 15-year population-based study.

Authors:  Carmela Di Gregorio; Piero Benatti; Lorena Losi; Luca Roncucci; Giuseppina Rossi; Giovanni Ponti; Massimiliano Marino; Monica Pedroni; Alessandra Scarselli; Barbara Roncari; Maurizio Ponz de Leon
Journal:  Int J Colorectal Dis       Date:  2004-12-09       Impact factor: 2.571

7.  Analysis of microsatellite instability in stool DNA of patients with colorectal cancer using denaturing high performance liquid chromatography.

Authors:  Seok-Byung Lim; Seung-Yong Jeong; Il-Jin Kim; Dae Yong Kim; Kyung Hae Jung; Hee Jin Chang; Hyo Seong Choi; Dae Kyung Sohn; Hio Chung Kang; Yong Shin; Sang-Geun Jang; Jae-Hyun Park; Jae-Gahb Park
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

8.  The relationship between medical students' knowledge, confidence, experience, and skills related to colorectal cancer screening.

Authors:  Karen E Hauer; Luann Wilkerson; Arianne Teherani
Journal:  J Cancer Educ       Date:  2008       Impact factor: 2.037

9.  Interactions among physicians, patients, and first-degree relatives in the familial screening of colorectal cancer in France.

Authors:  Isabelle Ingrand; Sarah Dujoncquoy; Virginie Migeot; Véronique Ghadi; Michel Beauchant; Pierre Ingrand
Journal:  Patient Prefer Adherence       Date:  2008-02-02       Impact factor: 2.711

10.  Performance of epigenetic markers SEPT9 and ALX4 in plasma for detection of colorectal precancerous lesions.

Authors:  Marc Tänzer; Benjamin Balluff; Jürgen Distler; Kari Hale; Andreas Leodolter; Christoph Röcken; Bela Molnar; Roland Schmid; Catherine Lofton-Day; Tibor Schuster; Matthias P A Ebert
Journal:  PLoS One       Date:  2010-02-04       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.